| Title: | ATL/TV1102 Phase II Results Presented at the World Congress on Treatment and Research in Multiple Sclerosis Conference Call Summary |
| Price: | $54.00 |
| Publication Date: | Sep 22, 2008 |
| Source: | Thomson StreetEvents |
| Company: | Isis Pharmaceuticals |
| Report Type: | Brief |
| Abstract: | Edited Brief of ISIS conference call or presentation, 22-Sep-08 5:00pm ET |
| Brief Excerpt: | ...Results of ATL/TV#### Phase II international multicenter clinical study are encouraging and demonstrate highly significant effect for ATL/TV#### under disease activity in MS patients after only two months of dosing. ... |
| Word Count: | 4301 |
| Length: | 10 Pages |
| Ticker: | ISIS |
| Time: | 5:00pm ET |
| Related Report(s): | |
| Format: |
Adobe Acrobat
|
| Free Sample: |
Click
Here
to Download
|
Looking For Something Else?